iNtRON Biotechnology, Inc. (KOSDAQ: 048530)

iNtRON Biotechnology Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	40,553	40,987	25,811	75,170	59,926	53,329
Short-Term Investments	26.59	52.88	61,137	30,000	41.98	3,042
Trading Asset Securities	13,798	16,144	21,403	8,327	6,201	13,197
Cash & Short-Term Investments	54,377	57,184	108,351	113,497	66,169	69,568
Cash Growth	-18.80%	-47.22%	-4.53%	71.53%	-4.89%	147.09%
Accounts Receivable	880.28	1,988	3,778	9,754	11,766	2,753
Other Receivables	255.08	660.26	471.4	851.74	286.45	143.62
Receivables	1,143	2,648	4,250	10,641	12,207	2,953
Inventory	1,184	1,011	800.39	1,002	1,532	1,346
Prepaid Expenses	-	81.6	36.69	69.19	328.74	284.47
Other Current Assets	347.62	55.12	490.14	303.53	1,090	1,134
Total Current Assets	57,052	60,980	113,928	125,513	81,327	75,287
Property, Plant & Equipment	19,048	22,696	15,031	13,758	11,951	7,550
Long-Term Investments	12,749	12,784	9,514	10,592	4,151	1,070
Other Intangible Assets	1,363	1,405	1,386	1,213	1,135	1,182
Long-Term Deferred Tax Assets	-	-	-	1,153	830.02	2,553
Other Long-Term Assets	754.72	749.82	1,070	1,136	1,142	1,361
Total Assets	90,966	98,615	140,959	153,365	100,536	89,032
Accounts Payable	-	0.42	97	561.02	206.67	263.6
Accrued Expenses	1.47	-	5.34	2.38	-	19.43
Short-Term Debt	-	-	30,810	29,494	9,854	-
Current Portion of Long-Term Debt	-	-	-	-	-	676.42
Current Portion of Leases	168.48	144.61	174.98	132.88	259.68	301.2
Current Income Taxes Payable	-	-	-	1,267	352.73	-
Other Current Liabilities	947.72	640.94	1,130	1,796	2,030	3,415
Total Current Liabilities	1,118	785.97	32,218	33,254	12,704	4,675
Long-Term Debt	-	-	-	16,067	-	13,784
Long-Term Leases	252.57	258.29	286.37	61.62	174.27	306.35
Long-Term Deferred Tax Liabilities	72.4	83.99	1,565	-	-	-
Other Long-Term Liabilities	154.35	136.35	508.05	2,312	2,279	5,248
Total Liabilities	1,597	1,880	34,777	52,016	15,157	24,013
Common Stock	17,075	17,075	17,075	16,898	16,462	15,005
Additional Paid-In Capital	40,978	40,978	80,978	73,604	67,737	62,622
Retained Earnings	44,248	48,680	18,549	12,733	3,097	-11,682
Treasury Stock	-13,939	-10,960	-10,960	-1,967	-1,967	-1,967
Comprehensive Income & Other	1,007	960.68	538.31	81.52	-62.54	0.7
Total Common Equity	89,369	96,734	106,181	101,349	85,266	63,980
Minority Interest	-	-	-	-	-	55
Shareholders' Equity	89,369	96,734	106,181	101,349	85,379	65,019
Total Liabilities & Equity	90,966	98,615	140,959	153,365	100,536	89,032
Total Debt	421.05	402.91	31,271	45,756	10,288	15,068
Net Cash (Debt)	53,956	56,781	77,080	67,741	55,881	54,501
Net Cash Growth	-18.91%	-26.33%	13.79%	21.22%	2.53%	126.87%
Net Cash Per Share	1630.59	1710.73	2272.18	2008.38	1583.72	1638.50
Filing Date Shares Outstanding	32.72	33.19	33.19	33.73	32.86	29.94
Total Common Shares Outstanding	32.72	33.19	33.19	33.73	32.86	29.94
Working Capital	55,934	60,194	81,710	92,259	68,623	70,611
Book Value Per Share	2731.33	2914.42	3199.04	3004.79	2595.08	2136.62
Tangible Book Value	88,006	95,329	104,796	100,137	84,131	62,799
Tangible Book Value Per Share	2689.67	2872.08	3157.30	2968.84	2560.55	2097.16
Land	3,659	4,072	2,631	2,631	2,513	1,666
Buildings	13,172	13,567	7,269	7,488	7,381	3,794
Machinery	4,757	1,826	2,382	1,235	982.02	843.58

Source: S&P Capital IQ. Standard template. Financial Sources.